Markets & Regulations

(Thaweesak Saengngoen/iStock via Getty Images Plus)

Recent FDA COVID-19 actions and updates

By Jenni Spinner

The agency has been busy with actions related to the virus behind the pandemic, keeping an eye on vaccinations, emerging variants, and other concerns.

(Who_I_am/iStock via Getty Images Plus)

Tech Innovations: June 2021

By Jenni Spinner

This month’s roundup of new equipment, materials, tech partnerships and other news includes items from Ajinomoto, Evonik, Quanticate, Pharmasol, and more.

Pic:getty/CG6images

FDA approves Biogen’s Alzheimer's drug, Aduhelm

By Rachel Arthur

The US Food and Drug Administration (FDA) has approved Biogen’s Aduhelm (aducanumab) for the treatment of Alzheimer’s: making it the first new treatment approved for the disease since 2003.

(Khanisorn Chaokla/iStock via Getty Images Plus)

Tech Innovations: May 2021

By Jenni Spinner

This month’s roundup of new equipment, technology partnerships, and other news includes items from Ajinomoto, Elligo, Syneos, ACD/Labs and other companies.

(metamorworks/iStock via Getty Images Plus)

People on the Move: May 2021

By Jenni Spinner

This month’s roundup of new hires, investment funding, partnerships, and other industry news includes key firms such as Clinical Ink, Medable, CPhI, and Sterling Pharma.

(Panuwat Sikham/iStock via Getty Images Plus)

Tech Innovations: April 2021

By Jenni Spinner

This month’s roundup of new equipment, materials, digital solutions and other news includes items from Lonza, Waters, Eversana, Clinical Ink, and more.

(alphaspirit/iStock via Getty Images Plus)

IQVIA completes acquisition of Q2 Diagnostics

By Jenni Spinner

The clinical research tech specialists, which had held 60% of Q2 Diagnostics, will now wholly own the comprehensive clinical laboratory services company.

(OstapenkoOlena/iStock via Getty Images Plus)

People on the Move: April 2021

By Jenni Spinner

This month’s hires, promotions, acquisitions and other notable news includes Ajinomoto, Medable, Charles River, Immunai, AstraZeneca and other top firms.

© GettyImages/Pheelings Media

FDA rebuff for Keytruda in breast cancer indication

By Jane Byrne

A couple of new developments to report in relation to Merck, known as MSD outside the US and Canada: the first being the rejection by the US FDA of the company’s application to use its anti-PD-1 therapy, Keytruda, in certain breast cancer patients.

(Blue Planet Studio/iStock via Getty Images Plus)

People on the Move: March 2021

By Jenni Spinner

The companies announcing acquisitions, new hires, promotions and other news this month include Syneos, Elligo, PCI Pharma Services, I Holland and more.

(seb_ra/iStock via Getty Images Plus)

People on the Move: February 2021

By Jenni Spinner

This month’s announcements about industry hires, promotions, alliances and other important events includes Merck, Lonza, Medable and other key firms.

(VectorInspiration/iStock via Getty Images Plus)

Latest FDA COVID-19 updates and activity

By Jenni Spinner

The federal agency continues to keep researchers, pharma firms and citizens apprised of current happenings and research related to the virus and pandemic.

Follow us

Products

View more

Webinars